Comparison of Immediate Implant Placement With Titanium Mesh Versus Collagen Membrane in Type II Socket:

January 11, 2026 updated by: Misr International University

Comparison of Flapless Immediate Implant Placement With Titanium Mesh Versus Immediate Implants Placement With Collagen Membrane in Type II Socket: A Randomized Clinical Trial

Statement of the problem: Immediate implant placement is faced with several problems. One of the most important issues is dealing with defects in the buccal plate of bone in the esthetic zone.

Aim: The aim of this study is to assess the buccal bone thickness after augmentation with titanium mesh and xenograft upon flapless immediate implant placement.

Study Overview

Detailed Description

Statement of the problem: Immediate implant placement is faced with several problems. One of the most important issues is dealing with defects in the buccal plate of bone in the esthetic zone.

Aim: The aim of this study is to assess the buccal bone thickness after augmentation with titanium mesh and xenograft upon flapless immediate implant placement.

Materials and Methods: This parallel arm, randomized controlled clinical trial will involve systemically free patients with remaining roots or badly decayed teeth in the anterior region and buccal bone deficiency requiring implant placement. They will be randomly allocated to two equal groups. Group A (test group, n=10) will receive immediate implants (grafting with xenograft covered by titanium mesh covered by collagen membrane), while group B (test group, n=10) will receive immediate implants (grafting with xenograft covered by collagen membrane). The parameters ( buccal bone thickness & soft tissue thickness will be assessed at 6 & 12 months. Postoperative pain and swelling will be recorded daily by the patient for the 1st two weeks post surgically. Postoperative medication will be prescribed to the patient and postoperative instructions will be explained in detail. Follow-up will be performed to assess the parameters and to ensure performing proper oral hygiene. Data collected will be tabulated and statistically analyzed.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 123456
        • Faculty of oral & dental Medicine,Misr international University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Patients who have at least one remaining root or badly decayed tooth in anterior maxilla.
  2. Systemically free patients (American Society of Anesthesiologists I; ASA I)
  3. Patients aged from 21 to 50 years old
  4. Buccal bone partial deficiency (extraction socket type II)
  5. Good oral hygiene
  6. Accepts the follow-up period (cooperative patients)
  7. Patient accepts to provides an informed consent

Exclusion Criteria:

  1. Patients with habits that may jeopardize the implant longevity and affect the results of the study such as parafunctional habits such as bruxism
  2. Smokers
  3. Pregnant and lactating females

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: immediate implant with collagen membrane
immediate implant placement will be done and augmentation of the buccal bone will be done with xenograft and collagen membrane
augmentation of the buccal plate of bone with xenograft and collagen membrane
Active Comparator: immediate implant with titanium mesh
immediate implant placement will be done and augmentation of the buccal bone will be done with xenograft and titanium mesh
augmentation of the buccal plate of bone with xenograft and titanium mesh

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Buccal bone thickness
Time Frame: at baseline, 6 and 12 months
assessment of the Buccal bone thickness in mm using CBCT
at baseline, 6 and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Soft tissue thickness
Time Frame: at baseline 6 and 12 months
Soft tissue thickness will be assessed in mm using volumetric analysis method
at baseline 6 and 12 months
Keratinized tissue width
Time Frame: at baseline, 6 and 12 months
measurement of the keratinized tissue width in mm using periodontal probe
at baseline, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ahmed H Farid, Masters, Assistant Lecturer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

March 9, 2025

First Submitted That Met QC Criteria

March 9, 2025

First Posted (Actual)

March 13, 2025

Study Record Updates

Last Update Posted (Actual)

January 13, 2026

Last Update Submitted That Met QC Criteria

January 11, 2026

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PER5253015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Augmentation

Clinical Trials on collagen membrane

Subscribe